Siponimod supports remyelination in the non-supportive environment
Abstract Inflammatory demyelination, a hallmark of multiple sclerosis (MS) lesions, leads to functional impairments and progressive axonal loss over time. Although remyelination is thought to protect axons, endogenous regenerative processes are often incomplete or fail entirely in many MS patients....
Saved in:
| Main Authors: | Johann Krüger, Newshan Behrangi, David Schliep, Leo Heinig, Elise Vankriekelsvenne, Nicole Wigger, Markus Kipp |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-87825-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
D‐Aspartate treatment attenuates myelin damage and stimulates myelin repair
by: Valeria de Rosa, et al.
Published: (2018-12-01) -
Pilot functional magnetic resonance imaging study of clemastine‐aided functional recovery on a mouse model of demyelination
by: Ander Egimendia, et al.
Published: (2025-03-01) -
Siponimod-associated cystoid macular edema without known risk factors
by: Min Young Kim, et al.
Published: (2024-12-01) -
Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic?
by: Dennis Bourdette, et al.
Published: (2024-07-01) -
Inhibition of phosphodiesterase‐4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination
by: Yasir A. Syed, et al.
Published: (2013-10-01)